PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Bio-Synthesis, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bio-Synthesis Expands Proteomic Platform with Enhanced Peptide Tools - Bio-Synthesis has added multiple peptide tools that can help researchers design their project and receive immediate feedback based on specific parameters - BioSyn.com
Bio-Synthesis Expands Proteomic Platform with Enhanced Peptide Tools

 

NewswireToday - /newswire/ - Lewisville, TX, United States, 2012/01/31 - Bio-Synthesis has added multiple peptide tools that can help researchers design their project and receive immediate feedback based on specific parameters - BioSyn.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Bio-Synthesis Inc. (BSI), is proud to announce new peptide tools that can help researchers analyze and design their peptides more accurately and efficiently. By utilizing BSI’s homepage, users will have access to the Peptide Property Calculator, as well as the Peptide Library Design Tools.

The peptide property calculator is a comprehensive web-based tool which calculates the various physiochemical property of the protein sequence. This tool calculates properties like Chemical formulae, Molecular weight, Isoelectric point, Extinction Co-efficient, and more. The property calculator can also predict hydrophobic or hydrophyllic regions, secondary structures, transmembrane regions, flexible regions and the probability of input sequence on the surface of the cell.

The Peptide property Calculator can also handle any junk character entered by the user which would be impassively removed from the input sequence. End users are guided step-by-step to make use of the tool from the beginning to end and also to interpret the results coming out of the tool. Easy-to-use features allow for amino acid sequences to be entered in single letter code or even the three letter code. The resulting graph surfacing from the hydrophobicity and hydrophilicity plot can be exported or copied to various locations and scrutinized. The calculation of each feature in the tool is based on the algorithm taken from reference papers.

Bio-Synthesis has also implemented Peptide Library Design Tools to its rapid high-throughput parallel peptide synthesis platform. These seven powerful peptide library generation tools provide researchers with the ability to generate large numbers of screening peptides which involves epitope mapping, sequence optimization, and sequence stabilization. The designs can include libraries made from Overlapping, Alanine Scanning, Positional, Truncation, Random, Scramble, and T-Cell Truncated peptides.

The advanced tools are added to a long list of design programs provided by Bio-Synthesis. With the Peptide Property Calculation and the Peptide Library Design Tools now available, researchers can analyze their sequences and make immediate adjustments to their project.

About Bio-Synthesis

Bio-Synthesis (biosyn.com) is a manufacturer of custom peptide synthesis, antibodies, bioconjugates, DNA, RNA, PNA, organic synthesis, microarrays, gene synthesis, cloning, detection kits, cell line authentication, and a diverse number of bimolecular products for the biomedical/life science community worldwide.

With over 27 years of experience producing custom products for both research and pharmaceutical use, BSI has developed a reputation for both small and large scale synthesis using optimal processes that meet your specifications. BSI is a U.S. based company, therefore all products are exclusively manufactured at the state-of-the-art facilities in Lewisville, Texas.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Bio-Synthesis, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Bio-Synthesis Expands Proteomic Platform with Enhanced Peptide Tools

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Angela Ragan - BioSyn.com 
972-420-8505
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bio-Synthesis, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Bio-Synthesis, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

FDA Approves Genentech’s Actemra (Tocilizumab) for Giant Cell Arteritis
BTG and HealthLoop Collaborate on IO Loop™ - An Exclusive Service to Connect Patients and Interventional Oncologists throughout Treatment
BD and UniteOR Join Forces to Deliver an Integrated Tracking Solution for the Operating Room Setting
MDxHealth and Maastricht University Collaborate on Next Generation (Epi)genetic Cancer Diagnostics
BD to Invest $60 Million in Nebraska Manufacturing Facility
MDxHealth Announces New Contract with MediNcrease Health Plans Regarding ConfirmMDx and SelectMDx
Pulse Certified As A Level Four Multichannel Content Agency by Veeva
Earthly Mist - Opioid-Alternative Painkiller, Kratom Now Available in Oklahoma City
MDxHealth and Exact Sciences Sign Collaboration Agreement
BD Advances Efforts to Combat Antimicrobial Resistance with Enhanced Diagnostic Solution Offering
First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit MagLar, Inc.

Visit  JobsWare.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)